首页> 外文期刊>Neuropsychobiology >Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
【24h】

Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.

机译:神经型一氧化氮合酶1基因(NOS1)的功能多态性与日本人群主要抑郁症的情绪障碍和氟伏沙明反应的遗传关联分析。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIM: Nitric oxide has been reported to play a role in neural transmitter release and N-methyl-D-aspartate receptor activation, as well as to be related to oxidative stress. Abnormalities in both of these mechanisms are thought to be involved in the pathophysiology of mood disorders including major depressive disorder (MDD) and bipolar disorder (BP). In addition, several lines of evidence support an association between abnormalities in neuronal nitric oxide synthases (nNOS) and mood disorders. Therefore, we studied the association of nNOS gene (NOS1) and mood disorders and the efficacy of fluvoxamine treatment in Japanese MDD patients. MATERIALS AND METHODS: Using a single nucleotide polymorphism (SNP; rs41279104, also called ex1c), we conducted a genetic association analysis of case-control samples (325 MDD patients, 154 BP patients and 807 controls) in the Japanese population. In addition, we performed an association analysis between NOS1 and the efficacy of fluvoxamine treatment in 117 MDD patients. We defined a clinical response as a decrease of more than 50% in baseline SIGH-D (Structured Interview Guide for the Hamilton Rating Scale for Depression) score within 8 weeks, and clinical remission as an SIGH-D score of less than 7 at 8 weeks. RESULTS: We did not detect a significant association between NOS1 and MDD, BP or the fluvoxamine therapeutic response in MDD in allele/genotype-wise analysis. CONCLUSIONS: We did not detect an association between only one marker (rs41279104) in NOS1 and Japanese mood disorder patients and fluvoxamine response, but sample sizes were probably too small to allow a meaningful test. Moreover, because we did not perform an association analysis based on linkage disequilibrium and a mutation scan of NOS1, a replication of the study using a larger sample and based on linkage disequilibrium may be required for conclusive results.
机译:背景/目的:一氧化氮据报道在神经递质释放和N-甲基-D-天冬氨酸受体活化中起作用,并且与氧化应激有关。这两种机制的异常均被认为与情绪障碍的病理生理有关,包括重度抑郁症(MDD)和双相情感障碍(BP)。此外,一些证据支持神经元一氧化氮合酶(nNOS)异常与情绪障碍之间的关联。因此,我们研究了nNOS基因(NOS1)与情绪障碍的关系以及氟伏沙明治疗日本MDD患者的疗效。材料与方法:使用单核苷酸多态性(SNP; rs41279104,也称为ex1c),我们对日本人群中的病例对照样本(325名MDD患者,154名BP患者和807名对照)进行了遗传关联分析。此外,我们在117名MDD患者中进行了NOS1与氟伏沙明治疗疗效之间的关联分析。我们将临床反应定义为在8周内基线SIGH-D(汉密尔顿抑郁量表的结构化访谈指南)得分下降超过50%,而临床缓解率在8周时SIGH-D得分低于7周。结果:在等位基因/基因型分析中,我们未发现NOS1与MDD,BP或MDD中的氟伏沙明治疗反应之间存在显着关联。结论:我们没有检测到NOS1和日本情绪障碍患者中只有一种标记(rs41279104)与氟伏沙明反应之间存在关联,但样本量可能太小,无法进行有意义的测试。此外,由于我们没有基于连锁不平衡和NOS1的突变扫描进行关联分析,因此,为得出结论性结果,可能需要使用更大的样本并基于连锁不平衡进行研究复制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号